Abstract: This work presented a fractional-N digital PLL that leveraged pseudo-random phase modulation and demodulation technique to mitigate fractional spurs. By decoupling the periodicity of control ...

Learn more about whether Travere Therapeutics, Inc. or Zymeworks Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Modulation advances have fueled more efficient use of bandwidth, although conventional modulation formats still require allowance for upper and lower sidebands around the carrier frequency. Ultra ...

Biohaven Ltd. (NYSE: BHVN) ("Biohaven"), a global clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization ...

Atomic-scale imperfections in graphene transistors generate unique wireless fingerprints that cannot be copied or predicted, ...

Learn more about whether PTC Therapeutics, Inc. or Zymeworks Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

With this milestone, Mondego Bio is transitioning into clinical-stage operations and plans to initiate a first-in-human (FIH) Phase 1 clinical study in the first half of 2026.

Jonas Salk quietly built the polio vaccine through rigorous, methodical work in Pittsburgh: treating patients, refinin ...

Abstract: Utilizing periodic phase modulation (PPM) can shift the echo spectrum, affecting matched filtering (MF) processing, leading to time delay shift or amplitude attenuation. The prior works on ...

C-FORWARD is the Second Phase 3 Trial in the Global HCV Development Program; the First Phase 3 Trial, C-BEYOND, is Currently Enrolling Patients in the US and Canada Regimen has Potential Best-in-Class ...

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. In this paper, we investigate the potential of achieving polarization independent ...